Coldstream Capital Management Inc Cassava Sciences Inc Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SAVA
# of Institutions
166Shares Held
15.7MCall Options Held
2.11MPut Options Held
3.65M-
Black Rock Inc. New York, NY3.22MShares$5.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$3.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.03MShares$1.64 Million0.0% of portfolio
-
State Street Corp Boston, MA874KShares$1.4 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY790KShares$1.26 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $64.2M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...